Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?

Adnan Kastrati; Robert A. Byrne; Stefanie Schulz

doi:10.1016/j.jcin.2011.08.003

Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?

Adnan Kastrati
, Robert A. Byrne
, Stefanie Schulz

Former organisations of the Department of Clinical Medicine

Technical University of Munich

Research output: Contribution to journal › Editorial

13 Scopus citations

Original language	English
Pages (from-to)	1129-1132
Number of pages	4
Journal	JACC: Cardiovascular Interventions
Volume	4
Issue number	10
DOIs	https://doi.org/10.1016/j.jcin.2011.08.003
State	Published - Oct 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

antiplatelet therapy
clopidogrel
drug-eluting stent(s)

Access to Document

10.1016/j.jcin.2011.08.003

Cite this

@article{cc97251c9c044f4a94a975f608b1f4f7,

title = "Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?",

keywords = "antiplatelet therapy, clopidogrel, drug-eluting stent(s)",

author = "Adnan Kastrati and Byrne, \{Robert A.\} and Stefanie Schulz",

year = "2011",

month = oct,

doi = "10.1016/j.jcin.2011.08.003",

language = "English",

volume = "4",

pages = "1129--1132",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",